Biohit Oyj

Director's Dealing • Mar 3, 2017

Disclosure 349770

Biohit Oyj - Managers' transactions

Biohit Oyj - Managers' Transactions

Biohit Oyj - Managers' Transactions, March 3, 2017 at 11:00 am local time (EET) Person subject to the notification requirement Name: Korpela, Semi Position: Chief Executive Officer ---------------------------------------------------------------------- Initial Notification Reference number: 74370089ATTSNBXJVT29_20170302113238_1 ---------------------------------------------------------------------- Issuer Name: Biohit Oyj LEI: 74370089ATTSNBXJVT29 ---------------------------------------------------------------------- Transaction details Transaction date: 2017-03-01 Venue: NASDAQ HELSINKI LTD (XHEL) Nature of the transaction: Acquisition Instrument: Share ISIN: FI0009005482 Volume: 1240 Unit price: 5,29000 Euro Aggregated transactions Volume: 1240 Volume weighted average price: 5.29000 Euro Additional information: CEO Semi Korpela, Biohit Oyj tel. +358 9 773 861 investor.relations@biohit.fi www.biohithealthcare.com Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com